What did Anika Therapeutics pay for Parcus Medical?

Anika Therapeutics acquired Parcus Medical for $74.9M in 2020, equivalent to 6.00x revenue. Target revenue was approximately $12.5M.

What does Parcus Medical do?

Parcus Medical is a medical devices business.

What multiple did Anika Therapeutics pay for Parcus Medical?

6.00x revenue, based on disclosed deal value of $74.9M and disclosed financials.

M&A TRANSACTION · 2020

Parcus Medical acquired by Anika Therapeutics

$74.9M· 6.00x revenue

Target

Parcus Medical

Acquirer

Anika Therapeutics

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$12.5M

EBITDA

—

Deal Value

$74.9M

EV/EBITDA

—

Context

This $74.9M acquisition of Parcus Medical by Anika Therapeutics sits in the medical devices sub-vertical. Anika Therapeutics is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Parcus Medical acquisition.

Citation: ExitValue.ai. (2020). Parcus Medical acquired by Anika Therapeutics. https://exitvalue.ai/deals/parcus-medical-acquired-by-anika-therapeutics-hc-2020-0133